Home » Market News » DirectorsTalk Highlights » Volunteers for Covid infection could soon get the call in UK
Open Orphan PLC

Volunteers for Covid infection could soon get the call in UK

Alex Greer says he’d rather put himself directly in the path of the coronavirus than get blindsided by the disease after an evening at the pub or with friends. It’s a scenario that could soon become a reality.

Britain is moving closer to carrying out studies that would intentionally infect healthy people with the virus to help researchers in their quest for Covid-19 vaccines, and thousands of volunteers like Greer, a chemistry student at Durham University in northeast England, are ready to go. Open Orphan Plc, parent of human challenge trial specialist hVivo, has said it’s in talks with potential customers including the U.K. to conduct tests of Covid shots.

Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).